E-Learning

Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market

HYDERABAD (Reuters) -Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling with increasing rates of obesity and diabetes. U.S.-based Lilly and Danish Novo Nordisk have seen skyrocketing global demand for their innovative weight-loss drugs, with investor interest also boosting the drugmakers' valuations. Mounjaro, a once-weekly injection approved by India's drug regulator, is priced at 4,375 rupees ($50.67) for a 5 mg vial and 3,500 rupees ($40.54) for a 2.5 mg vial, its lowest doses, the company told Reuters exclusively.

Read more

In the Market: How Trump is driving Asia to diversify away from US

-President Donald Trump's tariffs and other policies have some financiers and officials in Asia predicting the remaking of the post-World War II economic order, leading to an urgent quest to diversify away from America. The period after World War II saw a global order underpinned by multilateral institutions, such as the United Nations and the World Bank. The United States emerged as the dominant force, with the dollar as the world's reserve currency.

Read more

U.S. stocks rise, dollar strengthens as strong data counters central banks' caution

NEW YORK (Reuters) -U.S. stocks extended their rally and the dollar strengthened as solid data helped investors look past notes of caution from world central bank leaders regarding mounting economic uncertainties and U.S. President Donald Trump's erratic tariff policies. U.S. data showed jobless claims holding steady and an unexpected increase in existing home sales, which helped calm fears that the economy is softening, despite the U.S. Federal Reserve's lowered economic projections released on Wednesday. Straight on the heels of the Fed's decision to hold rates steady, the Bank of England (BoE) followed suit, holding its key interest rate steady while cautioning against assumptions it would cut rates in the near future as it grapples with economic uncertainties.

Read more